Effects of AAV-TAFAZZIN in Barth Syndrome Patient-Derived iPSC Cardiomyocytes and Myoblasts
Publication
, Conference
Venigalla, SL; D'Souza, R; Suzuki-Hatano, S; Kang, PB; Byrne, BJ; Cade, WT; Pacak, CA
Published in: MOLECULAR THERAPY
2023
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2023
Volume
31
Issue
4
Start / End Page
313 / 313
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Venigalla, S. L., D’Souza, R., Suzuki-Hatano, S., Kang, P. B., Byrne, B. J., Cade, W. T., & Pacak, C. A. (2023). Effects of AAV-TAFAZZIN in Barth Syndrome Patient-Derived iPSC Cardiomyocytes and Myoblasts. In MOLECULAR THERAPY (Vol. 31, pp. 313–313).
Venigalla, Sree L., Russell D’Souza, Silveli Suzuki-Hatano, Peter B. Kang, Barry J. Byrne, W Todd Cade, and Christina A. Pacak. “Effects of AAV-TAFAZZIN in Barth Syndrome Patient-Derived iPSC Cardiomyocytes and Myoblasts.” In MOLECULAR THERAPY, 31:313–313, 2023.
Venigalla SL, D’Souza R, Suzuki-Hatano S, Kang PB, Byrne BJ, Cade WT, et al. Effects of AAV-TAFAZZIN in Barth Syndrome Patient-Derived iPSC Cardiomyocytes and Myoblasts. In: MOLECULAR THERAPY. 2023. p. 313–313.
Venigalla, Sree L., et al. “Effects of AAV-TAFAZZIN in Barth Syndrome Patient-Derived iPSC Cardiomyocytes and Myoblasts.” MOLECULAR THERAPY, vol. 31, no. 4, 2023, pp. 313–313.
Venigalla SL, D’Souza R, Suzuki-Hatano S, Kang PB, Byrne BJ, Cade WT, Pacak CA. Effects of AAV-TAFAZZIN in Barth Syndrome Patient-Derived iPSC Cardiomyocytes and Myoblasts. MOLECULAR THERAPY. 2023. p. 313–313.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2023
Volume
31
Issue
4
Start / End Page
313 / 313
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences